Site-specific cleavage of RNA by Fe(II).bleomycin.

AUTOR(ES)

Carter, B J

RESUMO

Bleomycin is an antitumor agent whose activity has long been thought to derive from its ability to degrade DNA. Recent findings suggest that cellular RNA may be a therapeutically relevant locus. At micromolar concentrations, Fe(II)-bleomycin readily cleaved a Bacillus subtilis tRNAHis precursor in a highly selective fashion, but Escherichia coli tRNA(Tyr) precursor was largely unaffected even under more forcing conditions. Other substrates included an RNA transcript encoding a large segment of the reverse transcriptase from human immunodeficiency virus 1. RNA cleavage was oxidative, approximately 10-fold more selective than DNA cleavage, and largely unaffected by nonsubstrate RNAs. RNA sequence analysis suggested recognition of RNA tertiary structure, rather than recognition of specific sequences; subsets of nucleotides at the junction of single- and double-stranded regions were especially susceptible to cleavage. The ready accessibility of cellular RNAs to xenobiotic agents, the high selectivity of bleomycin action on RNAs, and the paucity of mechanisms for RNA repair suggest that RNA may be a therapeutically relevant target for bleomycin.

Documentos Relacionados

• Site-specific cleavage of supercoiled DNA by ascorbate/Cu(II).
• Catalytic site-specific cleavage of a DNA-target by an oligonucleotide carrying bleomycin A5.
• Site-specific cleavage of natural mRNA sequences by newly designed hairpin catalytic RNAs.
• Site-specific RNA cleavage generates the 3' end of a poxvirus late mRNA.
• Kinetics and regulation of site-specific endonucleolytic cleavage of human IGF-II mRNAs